[1]
2018. Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S54. DOI:https://doi.org/10.25251/skin.2.supp.54.